Efficacy of preservative-free tafluprost in patients with normal-tension glaucoma previously treated with latanoprost

Código QR

Efficacy of preservative-free tafluprost in patients with normal-tension glaucoma previously treated with latanoprost

Matteo Sacchi, Edoardo Villani, Paolo NucciUniversity Eye Clinic, San Giuseppe Hospital, University of Milan, Milan, ItalyWe read with interest the article entitled "Effects of tafluprost treatment for 3 years in patients with normal-tension glaucoma" by Inoue et al.1 In this stud...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Sacchi M, Villani E, Nucci P
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/a469673745ca4e05bac70b77487cb5c3
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Comparison study of intraocular pressure reduction efficacy and safety between latanoprost and tafluprost in Japanese with normal-tension glaucoma
por: Ikeda Y, et al.
Publicado: (2016)

Effects of preservative-free tafluprost on tear film osmolarity, tolerability, and intraocular pressure in previously treated patients with open-angle glaucoma
por: Janulevičienė I, et al.
Publicado: (2012)

Efficacy and tolerability of preservative-free tafluprost 0.0015% in Korean patients with glaucoma
por: Hwang YH
Publicado: (2013)

Effects of tafluprost treatment for 3 years in patients with normal-tension glaucoma
por: Inoue K, et al.
Publicado: (2013)

Preservative-free tafluprost in the treatment of naive patients with glaucoma and ocular hypertension
por: Lanzl I, et al.
Publicado: (2013)

The clinical effectiveness of tafluprost on Japanese normal-tension glaucoma patients
por: Nomura A, et al.
Publicado: (2018)

Differential pharmacology and clinical utility of preservative-free tafluprost in the treatment of ocular hypertension and glaucoma
por: Ermiş&nbsp;SS
Publicado: (2012)

Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost
por: Gregory Katz, et al.
Publicado: (2010)

Switching patients from preserved prostaglandin-analog monotherapy to preservative-free tafluprost
por: Hommer A, et al.
Publicado: (2011)

A randomized crossover study comparing tafluprost 0.005% with travoprost 0.004% in patients with normal-tension glaucoma
por: Mizoguchi T, et al.
Publicado: (2012)

Ocular Surface Changes After Switching from Other Prostaglandins to Tafluprost and Preservative-Free Tafluprost in Glaucoma Patients
por: Ruangvaravate N, et al.
Publicado: (2020)

Bimatoprost 0.01% or 0.03% in patients with glaucoma or ocular hypertension previously treated with latanoprost: two randomized 12-week trials
por: Myers JS, et al.
Publicado: (2014)

Latanoprost in the treatment of glaucoma
por: Alm A
Publicado: (2014)

Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction [Corrigendum]
por: Muñoz Negrete FJ, et al.
Publicado: (2017)

The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients
por: Tsumura T, et al.
Publicado: (2014)

Serum free fatty acids levels not associated with normal tension glaucoma
por: Kenya Yuki, et al.
Publicado: (2010)

Efficacy and tolerability of benzalkonium chloride-free travoprost in glaucoma patients switched from benzalkonium chloride-preserved latanoprost or bimatoprost
por: García-Feijoo J, et al.
Publicado: (2016)

The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum]
por: Tsumura T, et al.
Publicado: (2015)

Intraocular pressure and visual field changes in normal-tension glaucoma patients treated using either unoprostone or latanoprost: a prospective comparative study
por: Takemoto D, et al.
Publicado: (2017)

The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum]
por: Tsumura T, et al.
Publicado: (2015)

Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction
por: Beck DER, et al.
Publicado: (2017)

Better tolerance of preservative-free latanoprost compared to preserved glaucoma eye drops: the 12-month real-life FREE study
por: Economou MA, et al.
Publicado: (2018)

Efficacy and safety of benzalkonium chloride-free fixed-dose combination of latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension
por: Bhagat P, et al.
Publicado: (2014)

Effects of BAK-free travoprost treatment for 3 years in patients with normal tension glaucoma
por: Inoue K, et al.
Publicado: (2012)

Continuous 24-hour ocular dimensional profile recording in medically treated normal-tension glaucoma
por: Lee JWY, et al.
Publicado: (2015)

Benefits of switching from latanoprost to preservative-free tafluprost eye drops: a meta-analysis of two Phase IIIb clinical trials
por: Uusitalo H, et al.
Publicado: (2016)

Efficacy of a preservative-free formulation of fixed-combination bimatoprost and timolol (Ganfort PF) in treatment-naïve patients vs previously treated patients
por: Cordeiro MF, et al.
Publicado: (2015)

Efficacy of intravitreal dexamethasone implant for prostaglandin-induced refractory pseudophakic cystoid macular edema: case report and review of the literature
por: Sacchi M, et al.
Publicado: (2014)

Travoprost with sofZia® preservative system lowered intraocular pressure of Japanese normal tension glaucoma with minimal side effects
por: Mizoue S, et al.
Publicado: (2014)

The diurnal and nocturnal effects of travoprost in normal-tension glaucoma
por: Seibold LK, et al.
Publicado: (2014)

Differential activity and clinical utility of latanoprost in glaucoma and ocular hypertension
por: Pacella F, et al.
Publicado: (2012)

Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction
por: Muñoz Negrete FJ, et al.
Publicado: (2017)

A randomized, controlled comparison of macroscopic conjunctival hyperemia in patients treated with bimatoprost 0.01% or vehicle who were previously controlled on latanoprost
por: E Randy Craven, et al.
Publicado: (2010)

Optic disc topography in Malay patients with normal-tension glaucoma and primary open-angle glaucoma
por: Adlina AR, et al.
Publicado: (2014)

Tafluprost once daily for treatment of elevated intraocular pressure in patients with open-angle glaucoma
por: Liu Y, et al.
Publicado: (2012)

Effect of travoprost on 24-hour intraocular pressure in normal tension glaucoma
por: Yuya Nomura, et al.
Publicado: (2010)

Safety and tolerability of tafluprost in treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
por: Dorota Pozarowska
Publicado: (2010)

Efficacy and tolerability of a large scale change in regimen from latanoprost to travoprost in glaucoma patients at the Manhattan Veterans Administration Hospital
por: Edmund P Farris
Publicado: (2008)

Superior segmental optic nerve hypoplasia accompanied by progressive normal-tension glaucoma
por: Yamazaki Y, et al.
Publicado: (2012)

Comparison between bimatoprost and latanoprost-timolol fixed combination for efficacy and safety after switching patients from latanoprost
por: Maruyama Y, et al.
Publicado: (2015)